These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9712461)

  • 61. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
    Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
    Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
    Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
    Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oliguric acute renal failure following oral valacyclovir therapy.
    Sugimoto T; Yasuda M; Sakaguchi M; Koyama T; Uzu T; Kashiwagi A; Isshiki K; Kanasaki M
    QJM; 2008 Feb; 101(2):164-6. PubMed ID: 18180255
    [No Abstract]   [Full Text] [Related]  

  • 65. Valacyclovir pharmacokinetics and exploratory pharmacodynamics in young adults with Epstein-Barr virus infectious mononucleosis.
    Vezina HE; Balfour HH; Weller DR; Anderson BJ; Brundage RC
    J Clin Pharmacol; 2010 Jul; 50(7):734-42. PubMed ID: 19897764
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
    Kimberlin DF; Weller S; Whitley RJ; Andrews WW; Hauth JC; Lakeman F; Miller G
    Am J Obstet Gynecol; 1998 Oct; 179(4):846-51. PubMed ID: 9790357
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New drugs--reports of new drugs recently approved by the FDA. Valacyclovir.
    Shinkai I; Ohta Y
    Bioorg Med Chem; 1996 Jan; 4(1):1-2. PubMed ID: 8689229
    [No Abstract]   [Full Text] [Related]  

  • 68. Valaciclovir-induced hepatitis.
    Renkes P; Trechot P; Blain H
    Acta Clin Belg; 1999; 54(1):17-8. PubMed ID: 10192972
    [No Abstract]   [Full Text] [Related]  

  • 69. Failure of valacyclovir for herpes zoster in a moderately immunocompromised HIV-infected patient.
    Breton G; Bouldouyre MA; Gervais A; Duval X; Longuet P; Leport C; Vildé JL
    AIDS Patient Care STDS; 2004 May; 18(5):255-7. PubMed ID: 15186709
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recurrent erythema multiforme unresponsive to acyclovir prophylaxis and responsive to valacyclovir continuous therapy.
    Kerob D; Assier-Bonnet H; Esnault-Gelly P; Blanc F; Saiag P
    Arch Dermatol; 1998 Jul; 134(7):876-7. PubMed ID: 9681359
    [No Abstract]   [Full Text] [Related]  

  • 71. Successful use of oral valacyclovir in post-transplant cytomegalovirus infection in renal allograft recipients.
    Himmelmann-Jud B; Wüthrich RP; Weinreich T; Binswanger U
    Nephrol Dial Transplant; 1998 May; 13(5):1326-7. PubMed ID: 9623588
    [No Abstract]   [Full Text] [Related]  

  • 72. Prophylaxis of cytomegalovirus infection in renal transplantation.
    Ostermann M; MacPhee I; Chang R
    Nephrol Dial Transplant; 2001 Nov; 16(11):2276-9. PubMed ID: 11682689
    [No Abstract]   [Full Text] [Related]  

  • 73. Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.
    Winston DJ; Yeager AM; Chandrasekar PH; Snydman DR; Petersen FB; Territo MC;
    Clin Infect Dis; 2003 Mar; 36(6):749-58. PubMed ID: 12627359
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Valacyclovir and acute renal failure.
    Chavannes M; Doad RS; Doad GJS
    J Med Assoc Ga; 2016; 105(3):14. PubMed ID: 29809345
    [No Abstract]   [Full Text] [Related]  

  • 75. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial.
    Tyring SK; Plunkett S; Scribner AR; Broker RE; Herrod JN; Handke LT; Wise JM; Martin PA;
    J Med Virol; 2012 Aug; 84(8):1224-32. PubMed ID: 22711350
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A pilot study examining the safety and tolerability of valacyclovir in veterans with hepatitis C virus/herpes simplex virus type 2 coinfection.
    Burton MJ; Penman A; Sunesara I; McGuire BM; Hook EW
    Am J Med Sci; 2014 Dec; 348(6):455-9. PubMed ID: 25163019
    [TBL] [Abstract][Full Text] [Related]  

  • 77. More about acyclovir neurotoxicity in patients on haemodialysis.
    Gómez Campderá FJ; Verde E; Vozmediano MC; Valderrábano F
    Nephron; 1998; 78(2):228-9. PubMed ID: 9496746
    [No Abstract]   [Full Text] [Related]  

  • 78. Valacyclovir for the management of herpes viral infections.
    Chakrabarty A; Anderson NJ; Beutner R; Tyring SK
    Skin Therapy Lett; 2005 Feb; 10(1):1-4. PubMed ID: 15776202
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of safety and efficacy of prolonged suppressive therapy of genital herpes with valacyclovir.
    Durglishvili N; Shishniashvili D; Kvirkvelia V
    Georgian Med News; 2009; (172-173):47-9. PubMed ID: 19644189
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Valacyclovir. New indication: for genital herpes, simpler administration.
    Can Fam Physician; 1999 Jul; 45():1698-700, 1703-5. PubMed ID: 10424269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.